Welcome to

Ipsen US
Medical Information

We are a global biopharmaceutical leader dedicated to improving lives through innovative medicines in oncology, neuroscience, and rare diseases.

The US Ipsen Medical Information Team aims to provide responses to inquiries with the most current, accurate and complete medical information about our products in a timely manner.

Submit a Question

You can also Ask a Medical Information Question

Here

Contact us

To request medical information on Ipsen’s US products or report a complaint, please contact our USA Medical Information Call Center at:

Phone: 1-855-463-5127

Fax: 1-855-631-0644

Report an adverse event

If you think you or someone you know has experienced an adverse reaction to an Ipsen product, please contact Ipsen Biopharmaceuticals, Inc. at 1-855-463-5127.
Adverse reactions may also be reported to the FDA at
1-800-FDA-1088 or www.fda.gov/medwatch

ONIVYDE® is a registered trademark of Ipsen Biopharm Limited. SOMATULINE® DEPOT is a registered trademark of Ipsen Pharma S.A.

DYSPORT® is a registered trademark of Ipsen Biopharm Limited. INCRELEX® is a registered trademark of Ipsen Biopharmaceuticals, Inc.

TAZVERIK® is a registered trademark of Epizyme, Inc. an Ipsen company.

Welcome to the Ipsen US
Medical Information web site.

This web site is intended for use by healthcare professionals for contacting Ipsen Medical Information for current, accurate, and objective scientific and clinical information about the products Ipsen markets in the US.

PLEASE CHOOSE AN OPTION BELOW TO CONTINUE:

I AM A HEALTHCARE PROFESSIONAL IN THE US

I AM A HEALTHCARE PROFESSIONAL OUTSIDE OF THE US

I AM NOT A HEALTHCARE PROFESSIONAL

Please Select your speciality

  • Nurse
  • Physician
  • Physician Assistant
  • Researcher
  • Pharmacist
  • Therapist
  • HCP Other

You are now accessing the Ipsen US Medical Information Web Site.

The information you provide is needed to confirm your status as a US Healthcare Professional and to fulfil your request for medical information.

Your information will only be used for this purpose and will not be shared with anyone else except as required by law. For more information, please see our privacy policy

PROCEED